Alzheimer's beyond amyloidosis: WMHs matter, too, study finds

02/18/2013 | MolecularImaging.net

Amyloid accumulation may play a role in the development of Alzheimer’s disease, but it may not be enough to diagnose the disease, according to a study published in JAMA Neurology. Small-vessel cerebrovascular disease, which manifests as white matter hyperintensities, may also play a role in the development of the disease, the study said, and the combined factors appear to be involved in manifestation of disease. The researchers used C-11-PIB-PET imaging to detect amyloid buildup and structural MRI to measure WMH. "The findings suggest a role of small-vessel cerebrovascular disease in the clinical presentation of AD and point to the importance of incorporating WMH into the formulation of pathogenic models of the disease," the researchers wrote.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA